enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 8-K
Filing Date: 09 Mar 2026Report Date: 09 Mar 2026
Accepted: 09 Mar 2026 05:15 a.m.
Accession Number: 0001193125-26-097546
File Number: 001-41854
Film Number: 26733170
Items: 1.01,1.02,9.01
Documents
Primary Document: 8-K
Accepted: 09 Mar 2026 05:15 a.m.
0001193125-26-097546-index-headers.html
Last Modified: 09 Mar 2026 05:15 a.m.
0001193125-26-097546-index.html
Last Modified: 09 Mar 2026 05:15 a.m.
0001193125-26-097546.txt
Last Modified: 09 Mar 2026 05:15 a.m.
0001193125-26-097546-xbrl.zip
Last Modified: 09 Mar 2026 05:15 a.m.
engn-20260309.xsd
Last Modified: 09 Mar 2026 05:15 a.m.
engn-20260309_htm.xml
Last Modified: 09 Mar 2026 05:15 a.m.
engn-ex1_1.htm
Last Modified: 09 Mar 2026 05:15 a.m.
engn-ex5_1.htm
Last Modified: 09 Mar 2026 05:15 a.m.
FilingSummary.xml
Last Modified: 09 Mar 2026 05:15 a.m.
img93391562_0.jpg
Last Modified: 09 Mar 2026 05:15 a.m.
MetaLinks.json
Last Modified: 09 Mar 2026 05:15 a.m.
R1.htm
Last Modified: 09 Mar 2026 05:15 a.m.
report.css
Last Modified: 09 Mar 2026 05:15 a.m.
Show.js
Last Modified: 09 Mar 2026 05:15 a.m.